Last updated: June 5, 2026

Back to directory

Asensus Intelligent Surgical Unit medical AI product profile

FDA-cleared and internationally authorized augmented-intelligence platform that adds machine-vision and digital tools to the Senhance robotic surgery workflow.

Screenshot of the official Asensus Intelligent Surgical Unit product page
Surgery and procedural intelligence

Best fit

Surgical programs evaluating Senhance robotic surgery with real-time visual guidance, camera-control assistance, and data-driven digital augmentation.

Primary use case
Augmented-intelligence support for robotic surgery, machine-vision camera control, digital tools, visual guidance, and procedure-data insights with the Senhance Surgical System
Audience
Robotic surgery programs, minimally invasive surgeons, OR leaders, biomedical engineering teams, and medical-device governance committees
Risk level
High
Pricing signal
Device and service pricing through Asensus or KARL STORZ channels; verify current Senhance, ISU, training, service, and regional availability.
Official sources
4 official sources

Compare within workflow: Surgery and procedural intelligence · comparison shortlist · source index

Regulatory, privacy, evidence, and workflow lens

Product-specific review. These product-specific signals summarize what the cited sources imply before treating Asensus Intelligent Surgical Unit as safe for a local clinical, operational, or research workflow.

Regulatory / FDAConfirm authorization, labeling, intended use, software version, geography, and enabled features because robotic-surgery systems require device governance and procedure-specific credentialing.
PrivacyReview procedure-data capture, video, telemetry, analytics, service access, cybersecurity controls, retention, and whether data leaves the hospital or device environment.
EvidenceAssess setup burden, camera-control accuracy, surgeon ergonomics, visual-guidance reliability, conversion planning, adverse events, and procedure-specific outcomes during local adoption.
WorkflowBest evaluated as a surgeon-controlled robotic surgery adjunct with formal training, biomedical engineering oversight, fallback procedures, and post-deployment device monitoring.

Where Asensus Intelligent Surgical Unit fits

Asensus describes the Intelligent Surgical Unit as a real-time augmented-intelligence platform for the Senhance Surgical System, with FDA clearance, CE Mark, PMDA approval, machine-vision-enabled camera control, digital tools, and procedure-data insights for robotic surgery.

Not for: Autonomous robotic surgery, unsupported procedures, or using augmented-intelligence features outside cleared indications and surgeon-controlled workflows.

What to verify before using Asensus Intelligent Surgical Unit

Source links

Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.

Related medical AI products